Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks flat ahead of US data, Fed decision

Wed, 30th Jul 2014 11:42

- Corporate earnings receive mixed market reaction- Barclays, Travis Perkins and Astra rise- Antofagasta, ITV and Compass fall- US data, Fed decision in focus later ontechMARK 2,783.73 +0.05%FTSE 100 6,803.99 -0.06%FTSE 250 15,675.20 -0.08%The FTSE 100 was trading broadly flat on Wednesday, teetering at the 6,800 level, as investors gave a mixed reaction to a flurry of corporate earnings and awaited key economic data from the States.Meanwhile, traders were still watching developments in the Ukraine crisis after US and EU leaders announced a fresh round of sanctions on Russia yesterday. Relentless fighting in Gaza and a potential debt default in Argentina were also likely to be weighing on risk appetite.London's benchmark index was 0.1% lower at 6,804 by midday as strong gains from Barclays, Travis Perkins and AstraZeneca were offset by falls from Antofagasta, ITV and Compass.After a relatively quiet start to the week on the macro calendar, things will pick up this afternoon with the focus on the closely-watched ADP employment report and second-quarter gross domestic product (GDP) estimates in the States, as well as the Federal Reserve's policy decision scheduled for this evening.The consensus forecast is for annualised US GDP growth to be 3% in the second quarter of 2014, a sharp rebound from the 2.9% contraction registered in the first quarter.As for the Fed, there will not be a press conference but the central bank's statement is likely to have a "dovish twist", according to analysts at Danske Bank, "giving an acknowledgement that the labour market is improving faster than expected". Barclays leads banks higherBarclays was up 4% as it reported a less-than-expected 12% fall in total income adjusted for insurance claims for the first half to £13.32bn, driven by reductions at its investment and African banking units. The consensus estimate had been for a drop to £13.23bn. Domestic banking peers RBS and Lloyds were also on the rise.Housebuilder Travis Perkins also impressed as it reported double-digit growth across the board in the first half, with like-for-like revenues up 10.2% and profits up 16%. The company said it expects "continued solid growth" for the rest of the year.Astrazeneca was in demand after it struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. The initial consideration is $875m.Chile-focused mining group Antofagasta underwhelmed as it maintained its production guidance for 2014 after a sequential increase in output in the second quarter, while net cash costs were broadly flat. Shares of broadcaster ITV were in negative territory with the stock retreating after its recent strong run. Nevertheless, the company managed to beat expectations with its first-half results this morning with pre-tax profits up 16%.Catering and facilities management giant Compass served up a healthy third quarter of trading, improving margin across the group as revenue growth in North America remained strong while Europe and Japan improved. On the FTSE 250, retailer Pets at Home jumped after new store openings and strength in the food, accessories and services categories drove first-quarter revenues 10.4% higher.FTSE 100 - RisersBarclays (BARC) 228.10p +4.11%Travis Perkins (TPK) 1,700.00p +3.34%Royal Bank of Scotland Group (RBS) 361.60p +2.15%Capita (CPI) 1,238.00p +1.89%Carnival (CCL) 2,157.00p +1.41%Lloyds Banking Group (LLOY) 76.65p +1.35%Reckitt Benckiser Group (RB.) 5,280.00p +1.15%AstraZeneca (AZN) 4,362.00p +0.91%BAE Systems (BA.) 428.80p +0.78%BT Group (BT.A) 389.40p +0.62%FTSE 100 - FallersAntofagasta (ANTO) 834.00p -2.46%Sainsbury (J) (SBRY) 317.00p -1.95%Aberdeen Asset Management (ADN) 423.00p -1.79%ITV (ITV) 201.90p -1.51%Compass Group (CPG) 994.50p -1.34%BHP Billiton (BLT) 2,069.00p -1.29%GKN (GKN) 361.30p -1.28%3i Group (III) 388.60p -1.22%Morrison (Wm) Supermarkets (MRW) 172.40p -1.20%Ashtead Group (AHT) 920.50p -1.18%FTSE 250 - RisersPets at Home Group (PETS) 180.10p +5.94%Moneysupermarket.com Group (MONY) 189.60p +4.18%National Express Group (NEX) 265.10p +3.27%Cairn Energy (CNE) 182.80p +2.47%Diploma (DPLM) 640.00p +2.40%Bwin.party Digital Entertainment (BPTY) 87.90p +2.15%Phoenix Group Holdings (DI) (PHNX) 707.50p +2.02%PayPoint (PAY) 1,073.00p +2.00%Thomas Cook Group (TCG) 122.10p +2.00%Riverstone Energy Limited (RSE) 921.50p +1.82%FTSE 250 - FallersPace (PIC) 345.50p -4.53%International Personal Finance (IPF) 565.50p -3.50%Jupiter Fund Management (JUP) 401.70p -3.23%Just Eat (JE.) 205.10p -2.33%CSR (CSR) 538.00p -2.00%Hochschild Mining (HOC) 163.70p -1.98%Big Yellow Group (BYG) 500.50p -1.86%Infinis Energy (INFI) 235.80p -1.75%Dixons Retail (DXNS) 51.00p -1.73%Carphone Warehouse Group (CPW) 329.30p -1.70%BC
More News
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.